Literature DB >> 330978

Management of metastatic breast cancer.

C M Haskell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 330978     DOI: 10.1016/s0025-7125(16)31273-1

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


× No keyword cloud information.
  3 in total

1.  A randomized trial comparing mitoxantrone with doxorubicin in patients with stage IV breast cancer.

Authors:  J C Allegra; T Woodcock; S Woolf; I C Henderson; S Bryan; A Reisman; G Dukart
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

2.  First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancer.

Authors:  P Periti; G R della Cuna; F Pannuti; T Mazzei; P Preti; A Martoni; E Mini
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

3.  Pathobiology of breast cancer: hypothesis of biological predetermination and long-term survival.

Authors:  H Vorherr
Journal:  Klin Wochenschr       Date:  1981-08-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.